Patents by Inventor Wolfgang Wohlleben

Wolfgang Wohlleben has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10533199
    Abstract: An isolated protein or peptide, which is functional for a partial synthesis step of the biosynthesis of [S,S]-ethylenediamine-disuccinate, including or composed of an amino acid sequence selected from the group consisting of SEQ ID No. 39, SEQ ID No. 41, SEQ ID No. 43, SEQ ID No. 45, SEQ ID No. 47, SEQ ID No. 49, SEQ ID No. 51, SEQ ID No. 53, and combinations thereof.
    Type: Grant
    Filed: September 2, 2014
    Date of Patent: January 14, 2020
    Inventors: Efthimia Stegmann, Wolfgang Wohlleben, Marius Spohn, Tilmann Weber
  • Publication number: 20160215311
    Abstract: An isolated protein or peptide, which is functional for a partial synthesis step of the biosynthesis of [S,S]-ethylenediamine-disuccinate, including or composed of an amino acid sequence selected from the group consisting of SEQ ID No. 39, SEQ ID No. 41, SEQ ID No. 43, SEQ ID No. 45, SEQ ID No. 47, SEQ ID No. 49, SEQ ID No. 51, SEQ ID No. 53, and combinations thereof.
    Type: Application
    Filed: September 2, 2014
    Publication date: July 28, 2016
    Inventors: Efthimia Stegmann, Wolfgang Wohlleben, Marius Spohn, Tilmann Weber
  • Patent number: 6958417
    Abstract: A process for preparing a compound of formula (II) wherein R1 denotes bromine, wherein, a compound of formula (IV) is reacted with elemental bromine in a diluent.
    Type: Grant
    Filed: October 20, 2003
    Date of Patent: October 25, 2005
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Markus Sauter, Wolfgang Wohlleben
  • Patent number: 6828115
    Abstract: A description is given of epoxide hydrolases from bacteria of the genus Streptomyces, a novel process for the enzymatic separation of epoxide enantiomeric mixtures, of a novel detection method for epoxide hydrolase activity, a screening method for detecting epoxide hydrolase activity and the use of bacteria of the genus Streptomyces and of the resultant epoxide hydrolases for enantioselective epoxide hydrolysis.
    Type: Grant
    Filed: January 23, 2002
    Date of Patent: December 7, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Frank Zocher, Markus Enzelberger, Rolf D. Schmid, Wolfgang Wohlleben, Bernhard Hauer
  • Patent number: 6794170
    Abstract: The invention relates to a process halogenation, which comprises halogenating a chemical compound in the presence of a halogenase, where the halogenase is (a) encoded by the sequence specified in SEQ ID NO: 1 or a sequence derived therefrom on the basis of the degeneracy of the genetic code, or is (b) encoded by a nucleic acid sequence which codes for a functional fragment of (a) or (c) by a sequence which hybridizes with (a) or (b) under standard conditions, or is (d) encoded by a sequence which has more than 30% identity or more than 60% similarity with the sequence specified under (a).
    Type: Grant
    Filed: April 5, 2002
    Date of Patent: September 21, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Stefan Pelzer, Petra Huber, Roderich Suessmuth, Juergen Recktenwald, Dorothée Heckmann, Wolfgang Wohlleben
  • Publication number: 20040087794
    Abstract: A process for preparing a compound of formula (II) 1
    Type: Application
    Filed: October 20, 2003
    Publication date: May 6, 2004
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Markus Sauter, Wolfgang Wohlleben
  • Patent number: 6664421
    Abstract: The invention relates to a process for preparing a compound of formula (I) wherein a compound of formula (II), wherein R1 denotes chlorine, bromine, iodine, —O—COCH3, tosylate or mesylate, is reacted with a compound of formula (III),  optionally in a suitable diluent and/or in the presence of a suitable added reagent or catalyst, the reaction being carried out in a temperature range from 20 to 80° C.
    Type: Grant
    Filed: May 27, 2003
    Date of Patent: December 16, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Markus Sauter, Wolfgang Wohlleben
  • Publication number: 20030195375
    Abstract: The invention relates to a process for preparing a compound of formula (I) 1
    Type: Application
    Filed: May 27, 2003
    Publication date: October 16, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Markus Sauter, Wolfgang Wohlleben
  • Patent number: 6583285
    Abstract: The invention relates to a process for preparing a compound of formula (I) wherein a compound of formula (II),  wherein R1 denotes chlorine, bromine, iodine, —O—COCH3, tosylate or mesylate, is reacted with a compound of formula (III),  optionally in a suitable diluent and/or in the presence of a suitable added reagent or catalyst, the reaction being carried out in a temperature range from 20 to 80° C.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: June 24, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Markus Sauter, Wolfgang Wohlleben
  • Publication number: 20030109707
    Abstract: The invention relates to a process for preparing a compound of formula (I) 1
    Type: Application
    Filed: December 13, 2002
    Publication date: June 12, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Markus Sauter, Wolfgang Wohlleben
  • Publication number: 20030096335
    Abstract: The invention relates to a process halogenation, which comprises halogenating a chemical compound in the presence of a halogenase, where the halogenase is
    Type: Application
    Filed: April 5, 2002
    Publication date: May 22, 2003
    Inventors: Stefan Pelzer, Petra Huber, Roderich Suessmuth, Juergen Recktenwald, Dorothee Heckmann, Wolfgang Wohlleben
  • Patent number: 6566110
    Abstract: The invention relates to a process halogenation, which comprises halogenating a chemical compound in the presence of a halogenase, where the halogenase is (a) encoded by the sequence specified in SEQ ID NO: 1 or a sequence derived therefrom on the basis of the degeneracy of the genetic code, or is (b) encoded by a nucleic acid sequence which codes for a functional fragment of (a) or (c) by a sequence which hybridizes with (a) or (b) under standard conditions, or is (d) encoded by a sequence which has more than 30% identity or more than 60% similarity with the sequence specified under (a).
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: May 20, 2003
    Assignee: BASF Aktiengesellschaft
    Inventors: Stefan Pelzer, Petra Huber, Roderich Suessmuth, Juergen Recktenwald, Dorothee Heckmann, Wolfgang Wohlleben
  • Patent number: 6562975
    Abstract: The invention relates to a process for preparing a compound of formula (I) wherein a compound of formula (II),  wherein R1 denotes chlorine, bromine, iodine, —O—COCH3, tosylate or mesylate, is reacted with a compound of formula (III),  optionally in a suitable diluent and/or in the presence of a suitable added reagent or catalyst, the reaction being carried out in a temperature range from 20 to 80° C.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: May 13, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Markus Sauter, Wolfgang Wohlleben
  • Publication number: 20020183522
    Abstract: The invention relates to a process for preparing a compound of formula (I) 1
    Type: Application
    Filed: April 26, 2002
    Publication date: December 5, 2002
    Inventors: Markus Sauter, Wolfgang Wohlleben
  • Patent number: 6432685
    Abstract: The invention relates to a process for the oxidation of substituted trimethylcyclohexenyl compounds in the presence of microorganisms of the order Actinomycetales and to the use of microorganisms in oxidation reactions.
    Type: Grant
    Filed: October 11, 2000
    Date of Patent: August 13, 2002
    Assignee: BASF Aktiengesellschaft
    Inventors: Bernhard Hauer, Wolfgang Wohlleben, Peter Fischer, Sabine Lutz-Wahl, Claudia Schmidt-Dannert, Rolf D. Schmid, Oliver Scherr
  • Patent number: 5879903
    Abstract: Selection of Streptomyces viridochromogenes DSM 4112 for resistance to phosphinothricyl-alanyl-alanine (PTT) results in PTT-resistance selectants. The DNA fragment which carries the phosphinothricin(PTC)-resistance gene is obtained from the total DNA of these selectants by cutting with BamHI, cloning of a fragment 4.0 kb in size, and selection for PTT resistance. This gene is suitable for the production of PTC-resistant plants, and as a resistance marker and for the selective N-acetylation of the L-form of racemic PTC.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 9, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Eckhard Strauch, Wolfgang Wohlleben, Walter Arnold, Renate Alijah, Alfred Puhler, Gerhard Wohner, Rudiger Marquardt, Susanne Grabley, Dieter Brauer, Klaus Bartsch
  • Patent number: 5767370
    Abstract: Deacetylase genes for the production of phosphinothricin or phosphinothricyl-alanyl-alanine, processes for their isolation, and their use.The invention relates to deacetylase genes, to processes for their isolation, and to their use, in particular for the production of transgenic plants using tissue-specific promoters. It is possible to prevent the development of certain parts in these plants in a targeted manner. With the aid of deacetylase genes, it is furthermore possible to identify and isolate tissue-specific promoters in transgenic plants.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: June 16, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Inge Broer, Doris Hillemann, Alfred Puhler, Wolfgang Wohlleben, Gunter Donn, Hubert Mullner, Klaus Bartsch
  • Patent number: 5767371
    Abstract: Deacetylase genes for the production of phosphinothricin or phosphinothricyl-alanyl-alanine, processes for their isolation, and their use.The invention relates to deacetylase genes, to processes for their isolation, and to their use, in particular for the production of transgenic plants using tissue-specific promoters. It is possible to prevent the development of certain parts in these plants in a targeted manner. With the aid of deacetylase genes, it is furthermore possible to identify and isolate tissue-specific promoters in transgenic plants.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: June 16, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Inge Broer, Doris Hillemann, Alfred Puhler, Wolfgang Wohlleben, Gunter Donn, Hubert Mullner, Klaus Bartsch
  • Patent number: 5668297
    Abstract: The invention relates to deacetylase genes, to processes for their isolation, and to their use, in particular for the production of transgenic plants using tissue-specific promoters. It is possible to prevent the development of certain parts in these plants in a targeted manner. With the aid of deacetylase genes, it is furthermore possible to identify and isolate tissue-specific promoters in transgenic plants.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: September 16, 1997
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Inge Broer, Doris Hillemann, Alfred Puhler, Wolfgang Wohlleben, Gunter Donn, Hubert Mullner, Klaus Bartsch
  • Patent number: 5650310
    Abstract: The invention relates to deacetylase genes, to processes for their isolation, and to their use, in particular for the production of transgenic plants using tissue-specific promoters. It is possible to prevent the development of certain parts in these plants in a targeted manner. With the aid of deacetylase genes, it is furthermore possible to identify and isolate tissue-specific promoters in transgenic plants.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: July 22, 1997
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Inge Broer, Doris Hillemann, Alfred Puhler, Wolfgang Wohlleben, Gunter Donn, Hubert Mullner, Klaus Bartsch